Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Back-pack mice as a model of renal mesangial IgA dimers deposition.

Kennel-De March A, Prin-Mathieu C, Kohler CH, Kolopp-Sarda MN, Faure GC, Béné MV.

Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):701-8.

PMID:
16388718
2.

Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies.

Yan D, Rumbeiha WK, Pestka JJ.

Food Chem Toxicol. 1998 Dec;36(12):1095-106.

PMID:
9862652
3.

IgA production and tonsillar focal infection in IgA nephropathy.

Meng H, Ohtake H, Ishida A, Ohta N, Kakehata S, Yamakawa M.

J Clin Exp Hematop. 2012;52(3):161-70. Review.

4.

Role of complement in IgA nephropathy.

Daha MR, van Kooten C.

J Nephrol. 2016 Feb;29(1):1-4. doi: 10.1007/s40620-015-0245-6. Epub 2015 Nov 13. Review.

5.

O-glycosylated IgA rheumatoid factor induces IgA deposits and glomerulonephritis.

Otani M, Nakata J, Kihara M, Leroy V, Moll S, Wada Y, Izui S.

J Am Soc Nephrol. 2012 Mar;23(3):438-46. doi: 10.1681/ASN.2011070701. Epub 2011 Dec 22.

6.

Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.

Chen A, Ding SL, Sheu LF, Song YB, Shieh SD, Shaio MF, Chou WY, Ho YS.

Lab Invest. 1994 May;70(5):639-47.

PMID:
8196360
7.

Immunopathogenesis of IgAN.

Barratt J, Smith AC, Molyneux K, Feehally J.

Semin Immunopathol. 2007 Nov;29(4):427-43. Epub 2007 Sep 13. Review.

PMID:
17851660
8.

O-linked glycosylation determines the nephritogenic potential of IgA rheumatoid factor.

Kihara M, Ito K, Nakata J, Otani M, Tran NL, Morito N, Takahashi S, Wada Y, Izui S.

J Am Soc Nephrol. 2014 Jun;25(6):1282-90. doi: 10.1681/ASN.2013070771. Epub 2014 Feb 7.

9.
10.

Antigen as mediator of glomerular injury in experimental IgA nephropathy.

Montinaro V, Esparza AR, Cavallo T, Rifai A.

Lab Invest. 1991 Apr;64(4):508-19.

PMID:
2016857
11.

Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific.

van den Wall Bake AW, Bruijn JA, Accavitti MA, Crowley-Nowick PA, Schrohenloher RE, Julian BA, Jackson S, Kubagawa H, Cooper MD, Daha MR, et al.

Kidney Int. 1993 Jul;44(1):65-74.

12.

Clinical involvement of the tonsillar immune system in IgA nephropathy.

Béné MC, Faure GC, Hurault de Ligny B, de March AK.

Acta Otolaryngol Suppl. 2004 Dec;(555):10-4. Review.

PMID:
15768790
13.

Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.

Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.

J Am Soc Nephrol. 2005 Sep;16(9):2667-76. Epub 2005 Jun 29.

14.

Frequency of mesangial IgA deposits in a non-selected autopsy series.

Waldherr R, Rambausek M, Duncker WD, Ritz E.

Nephrol Dial Transplant. 1989;4(11):943-6.

PMID:
2516884
15.
16.

The kinetics of glomerular deposition of nephritogenic IgA.

Yamaji K, Suzuki Y, Suzuki H, Satake K, Horikoshi S, Novak J, Tomino Y.

PLoS One. 2014 Nov 19;9(11):e113005. doi: 10.1371/journal.pone.0113005. eCollection 2014.

18.

Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition.

van der Boog PJ, van Kooten C, van Zandbergen G, Klar-Mohamad N, Oortwijn B, Bos NA, van Remoortere A, Hokke CH, de Fijter JW, Daha MR.

Nephrol Dial Transplant. 2004 Nov;19(11):2729-36. Epub 2004 Aug 31.

PMID:
15340093
19.

Anti-idiotype antibody directly interferes with glomerular IgA immune complex deposition.

Chen A, Sheu LF, Shaio MF, Huang TH, Ding SL, Lee WH.

Nephron. 1998;78(4):464-73.

PMID:
9578073
20.

Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy.

Moura IC, Centelles MN, Arcos-Fajardo M, Malheiros DM, Collawn JF, Cooper MD, Monteiro RC.

J Exp Med. 2001 Aug 20;194(4):417-25.

Supplemental Content

Support Center